Published in Plast Reconstr Surg on January 01, 2012
Tranexamic Acid for Bleeding in Breast Surgery (TABBS) | NCT02615366
Chemoprophylaxis for venous thromboembolism prevention: concerns regarding efficacy and ethics. Plast Reconstr Surg Glob Open (2013) 0.84
The Case against Chemoprophylaxis for Venous Thromboembolism Prevention and the Rationale for SAFE Anesthesia. Plast Reconstr Surg Glob Open (2014) 0.78
Caprini Scores, Risk Stratification, and Rivaroxaban in Plastic Surgery: Time to Reconsider Our Strategy. Plast Reconstr Surg Glob Open (2016) 0.75
Does preoperative heparin increase the postoperative bleeding risk in women undergoing prosthetic breast implant surgery? A review of the data from a single institution. Plast Surg (Oakv) (2015) 0.75
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 11.84
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med (2010) 5.59
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet (2007) 5.41
Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med (2002) 3.91
Natural history of venous thromboembolism. Circulation (2003) 3.67
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg (2001) 3.67
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet (2010) 3.29
Thrombosis risk assessment as a guide to quality patient care. Dis Mon (2005) 2.13
Mortality in outpatient surgery. Plast Reconstr Surg (2008) 1.74
Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost (2008) 1.67
Venous thromboembolism following microsurgical breast reconstruction: an objective analysis in 225 consecutive patients using low-molecular-weight heparin prophylaxis. Plast Reconstr Surg (2011) 1.66
Incidence of hematoma complication with heparin venous thrombosis prophylaxis after TRAM flap breast reconstruction. Plast Reconstr Surg (2008) 1.56
Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Am J Surg (2010) 1.54
Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost (2006) 1.49
Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg (2010) 1.47
Our complication, your problem. Plast Reconstr Surg (2007) 1.47
Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines. Chest (2001) 1.39
Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery. Plast Reconstr Surg (2008) 1.31
Call to action to prevent venous thromboembolism. J Vasc Surg (2009) 1.17
Clarifying "never events and introducing "always events". Patient Saf Surg (2009) 1.16
Prevention of venous thromboembolism: adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients. Arch Intern Med (2000) 1.15
Prevention of venous thromboembolism in the plastic surgery patient. Plast Reconstr Surg (2004) 1.13
Efficacy and safety of venous thromboembolism prophylaxis in highest risk plastic surgery patients. Plast Reconstr Surg (2008) 1.11
Analysis of outpatient surgery center safety using an internet-based quality improvement and peer review program. Plast Reconstr Surg (2004) 1.09
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost (2007) 1.02
Prevention of venous thromboembolism in body contouring surgery: a national survey of 596 ASPS surgeons. Ann Plast Surg (2011) 1.02
Practice patterns in venous thromboembolism prophylaxis: a survey of 606 reconstructive breast surgeons. Ann Plast Surg (2010) 1.00
Venous thromboembolic disease in autogenous breast reconstruction. Ann Plast Surg (2009) 0.99
Plastic surgeon compliance with national safety initiatives: clinical outcomes and "never events". Plast Reconstr Surg (2010) 0.95
The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. Arch Surg (2006) 0.94
Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis. Cancer Treat Rev (2002) 0.93
Venous thromboembolism risk factor assessment and prophylaxis. Phlebology (2010) 0.92
The incidence of venous thromboembolism after oncologic head and neck reconstruction. Ann Plast Surg (2008) 0.90
Prevention and management of venous thromboembolism in the surgical patient: options by surgery type and individual patient risk factors. Am J Surg (2010) 0.86
VTE prophylaxis in aesthetic surgery patients. Aesthet Surg J (2009) 0.85
Anticoagulants and hematomas in free flap surgery. Plast Reconstr Surg (1995) 0.84
Low-molecular-weight heparin and postoperative bleeding in rhytidectomy. Plast Reconstr Surg (2006) 0.81
Free tissue transfer and deep vein thrombosis. J Plast Reconstr Aesthet Surg (2008) 0.80
Development of consensus guidelines for venous thromboembolism prophylaxis in patients undergoing microvascular reconstruction of the mandible. Head Neck (2010) 0.79
Statistics in medicine. Plast Reconstr Surg (2011) 0.77
The effect of blood pressure on hematoma formation with perioperative Lovenox in excisional body contouring surgery. Aesthet Surg J (2009) 0.76
The BREAST-Q: further validation in independent clinical samples. Plast Reconstr Surg (2012) 5.11
Medial thigh lift in the massive weight loss population: outcomes and complications. Plast Reconstr Surg (2015) 3.26
A paradigm shift in U.S. Breast reconstruction: increasing implant rates. Plast Reconstr Surg (2013) 3.00
The national utilization of immediate and early delayed breast reconstruction and the effect of sociodemographic factors. Plast Reconstr Surg (2003) 2.67
Stromal vascular progenitors in adult human adipose tissue. Cytometry A (2010) 2.53
A paradigm shift in U.S. breast reconstruction: Part 2. The influence of changing mastectomy patterns on reconstructive rate and method. Plast Reconstr Surg (2013) 2.51
Development and psychometric evaluation of the FACE-Q Aging Appraisal Scale and Patient-Perceived Age Visual Analog Scale. Aesthet Surg J (2013) 2.28
The effect of closed-suction drains on the incidence of local wound complications following tissue expander/implant reconstruction: a cohort study. Plast Reconstr Surg (2007) 2.27
Assessment of postoperative venous thromboembolism risk in plastic surgery patients using the 2005 and 2010 Caprini Risk score. Plast Reconstr Surg (2012) 2.25
Identifying and avoiding bias in research. Plast Reconstr Surg (2010) 2.19
Liposuction of the arm concurrent with brachioplasty in the massive weight loss patient: is it safe? Plast Reconstr Surg (2013) 2.13
Acellular human dermis implantation in 153 immediate two-stage tissue expander breast reconstructions: determining the incidence and significant predictors of complications. Plast Reconstr Surg (2010) 2.12
Reconstruction of extensive composite posterolateral mandibular defects using nonosseous free tissue transfer. Plast Reconstr Surg (2009) 2.04
Lower body lift after massive weight loss: autoaugmentation versus no augmentation. Plast Reconstr Surg (2015) 1.96
Is There a Safe Lipoaspirate Volume? A Risk Assessment Model of Liposuction Volume as a Function of Body Mass Index. Plast Reconstr Surg (2015) 1.95
Dynamics of Gluteal Cleft Morphology in Lower Body Lift: Predictors of Unfavorable Outcomes. Plast Reconstr Surg (2015) 1.92
Patient-physician concordance: preferences, perceptions, and factors influencing the breast cancer surgical decision. J Clin Oncol (2004) 1.92
Microvascular reconstruction of the hypopharynx: defect classification, treatment algorithm, and functional outcome based on 165 consecutive cases. Plast Reconstr Surg (2003) 1.91
Measuring quality of life in oncologic breast surgery: a systematic review of patient-reported outcome measures. Breast J (2010) 1.90
The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev (2011) 1.89
A systematic review of patient-reported outcome measures after facial cosmetic surgery and/or nonsurgical facial rejuvenation. Plast Reconstr Surg (2009) 1.88
The use of acellular dermal matrices in two-stage expander/implant reconstruction: a multicenter, blinded, randomized controlled trial. Plast Reconstr Surg (2012) 1.84
Complications in postmastectomy breast reconstruction: two-year results of the Michigan Breast Reconstruction Outcome Study. Plast Reconstr Surg (2002) 1.84
Breast cancer local recurrence after mastectomy and TRAM flap reconstruction: incidence and treatment options. Plast Reconstr Surg (2006) 1.74
Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg (2008) 1.72
Prevalence of endogenous CD34+ adipose stem cells predicts human fat graft retention in a xenograft model. Plast Reconstr Surg (2013) 1.70
Silicone breast implants and magnetic resonance imaging screening for rupture: do U.S. Food and Drug Administration recommendations reflect an evidence-based practice approach to patient care? Plast Reconstr Surg (2008) 1.69
Venous thromboembolism following microsurgical breast reconstruction: an objective analysis in 225 consecutive patients using low-molecular-weight heparin prophylaxis. Plast Reconstr Surg (2011) 1.66
Postoperative enoxaparin prevents symptomatic venous thromboembolism in high-risk plastic surgery patients. Plast Reconstr Surg (2011) 1.65
Measuring outcomes that matter to face-lift patients: development and validation of FACE-Q appearance appraisal scales and adverse effects checklist for the lower face and neck. Plast Reconstr Surg (2014) 1.63
A national snapshot of satisfaction with breast cancer procedures. Ann Surg Oncol (2014) 1.62
FACE-Q scales for health-related quality of life, early life impact, satisfaction with outcomes, and decision to have treatment: development and validation. Plast Reconstr Surg (2015) 1.62
Regional anatomic and age effects on cell function of human adipose-derived stem cells. Ann Plast Surg (2008) 1.61
Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast Reconstr Surg (2004) 1.58
Free-flap mandibular reconstruction: a 10-year follow-up study. Plast Reconstr Surg (2002) 1.57
Measuring patient-reported outcomes in facial aesthetic patients: development of the FACE-Q. Facial Plast Surg (2010) 1.56
Dextran-related complications in head and neck microsurgery: do the benefits outweigh the risks? A prospective randomized analysis. Plast Reconstr Surg (2003) 1.55
Anatomical landmarks to the superficial and deep palmar arches. Plast Reconstr Surg (2008) 1.54
CD4+ T cell responses elicited by different subsets of human skin migratory dendritic cells. J Immunol (2005) 1.52
Use of Acellular Dermal Matrix in Postmastectomy Breast Reconstruction: Are All Acellular Dermal Matrices Created Equal? Plast Reconstr Surg (2015) 1.49
Postmastectomy reconstruction: an approach to patient selection. Plast Reconstr Surg (2009) 1.48
Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg (2010) 1.47
Prospective analysis of long-term psychosocial outcomes in breast reconstruction: two-year postoperative results from the Michigan Breast Reconstruction Outcomes Study. Ann Surg (2008) 1.47
A report of the ASPS Task Force on regenerative medicine: opportunities for plastic surgery. Plast Reconstr Surg (2013) 1.45
Multiple procedures and staging in the massive weight loss population. Plast Reconstr Surg (2010) 1.44
Complications in postbariatric body contouring: postoperative management and treatment. Plast Reconstr Surg (2011) 1.43
Does the use of biopatch devices at drain sites reduce perioperative infectious complications in patients undergoing immediate tissue expander breast reconstruction? Plast Reconstr Surg (2015) 1.42
Patient satisfaction with postmastectomy breast reconstruction: a comparison of saline and silicone implants. Cancer (2010) 1.41
A randomized controlled trial of skin care protocols for facial resurfacing: lessons learned from the Plastic Surgery Educational Foundation's Skin Products Assessment Research study. Plast Reconstr Surg (2011) 1.41
Breast cancer in the previously augmented breast. Plast Reconstr Surg (2007) 1.40
Quality of Life and Patient-Reported Outcomes in Breast Cancer Survivors: A Multicenter Comparison of Four Abdominally Based Autologous Reconstruction Methods. Plast Reconstr Surg (2016) 1.40
Postmastectomy Radiation Therapy and Two-Stage Implant-Based Breast Reconstruction: Is There a Better Time to Irradiate? Plast Reconstr Surg (2016) 1.40
The Challenges of Augmentation Mastopexy in the Massive Weight Loss Patient: Technical Considerations. Plast Reconstr Surg (2017) 1.39
Should Immediate Autologous Breast Reconstruction be considered in Women who require Post-Mastectomy Radiation Therapy? A Prospective Analysis of Outcomes. Plast Reconstr Surg (2017) 1.39
Body Contouring. Plast Reconstr Surg (2016) 1.39
State of the Plastic Surgery Workforce and the Impact of Graduate Medical Education Reform on Training of Plastic Surgeons. Plast Reconstr Surg (2017) 1.38
Body image and quality of life in post massive weight loss body contouring patients. Obesity (Silver Spring) (2006) 1.38
Understanding and Overcoming Implicit Gender Bias in Plastic Surgery. Plast Reconstr Surg (2016) 1.38
An acellular biologic scaffold promotes skeletal muscle formation in mice and humans with volumetric muscle loss. Sci Transl Med (2014) 1.38
Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A (2010) 1.37
Role of gender and anatomical region on induction of osteogenic differentiation of human adipose-derived stem cells. Ann Plast Surg (2008) 1.29
Adipose tissue engineering for soft tissue regeneration. Tissue Eng Part B Rev (2010) 1.25
Patient-reported aesthetic satisfaction with breast reconstruction during the long-term survivorship Period. Plast Reconstr Surg (2009) 1.24
Unilateral postoperative chest wall radiotherapy in bilateral tissue expander/implant reconstruction patients: a prospective outcomes analysis. Plast Reconstr Surg (2005) 1.22
The effectiveness of surgical and nonsurgical interventions in relieving the symptoms of macromastia. Plast Reconstr Surg (2002) 1.21
A prospective surveillance model for rehabilitation for women with breast cancer. Cancer (2012) 1.21
Psychological considerations of the bariatric surgery patient undergoing body contouring surgery. Plast Reconstr Surg (2008) 1.19
Adipogenic potential of adipose stem cell subpopulations. Plast Reconstr Surg (2011) 1.19
The pyriform ligament. Plast Reconstr Surg (2008) 1.18